FOR HEALTHCARE & REGULATED CX
Patient and member research is uniquely hard, and the constraint is rarely the research team. CX leaders at payers, health systems, fintech, and insurance face recruitment timelines that stretch into months, narrow eligibility populations, regulated content review that can’t be skipped, and budgets that haven’t kept pace with the volume of digital products that need member feedback. Candor’s evidence-grounded synthetic respondents bypass the recruitment timing without bypassing the methodology rigor. Concept tests, journey-mapping research, and member-experience studies can proceed in hours rather than weeks of panel scheduling, with personas grounded in published patient and member research rather than AI imagination.
Healthcare and regulated CX teams aren’t slow because the teams are slow. They’re slow because the structural friction around respondent access is harder than anywhere else in research.
Recruitment is the bottleneck. Verified patient panels are smaller, more expensive (often 3 to 10 times the cost of consumer panels), and slower to field than B2C panel research. Many narrow-eligibility populations (specific condition cohorts, rare diagnoses, recent-claim members) take months to recruit at usable N.
Regulatory and content review constraints. Anything member-facing typically needs compliance review before fielding. Anything clinical-claim adjacent needs medical-affairs review. Anything member-protected needs privacy and security review. Each of these gates is necessary. Together, they make fast iteration nearly impossible.
Budget asymmetry. A consumer brand running many concept tests across a year operates on different cost math than a payer running concept tests across a member-app redesign. Per-respondent costs in healthcare research can dwarf the cost of the concepts themselves, which forces teams to test fewer concepts more cautiously rather than screening many cheaply.
Volume of digital-product surface area. Mobile member apps, patient portals, telehealth flows, claims surfaces, medication-adherence tools, member-onboarding journeys. Every regulated industry has materially expanded its digital surface area over the past several years, and the CX research function rarely staffs up at the same rate. The result is research-question volume growing faster than research throughput.
The result is a pattern most CX leaders will recognize: a backlog of digital-product research questions that the team wants to answer but can’t get to inside the launch timeline. Synthetic research changes the math on which questions can get respondent-grounded signal without waiting for the panel.
Candor’s synthetic personas are not AI improvisation. They are constructed from real evidence: published patient research, peer-reviewed studies on member experience and consumer-health behavior, public health datasets, and any first-party research a team uploads (interview transcripts, prior survey data, journey maps). Every attribute on every persona carries a provenance tag, so you can trace each statement back to its underlying source.
This matters for regulated industries in three specific ways.
Auditability. When a stakeholder asks where a finding came from, the answer is documented at the attribute level. The provenance trail is visible in every persona profile. This is closer to the documentation standards regulated industries already operate under than ad-hoc AI-research tools.
Methodology rigor. Personality traits are sampled from peer-reviewed OCEAN distributions by region and occupation. Cognitive biases are assigned at calibrated intensities from research catalogs. Every interview response is checked against the persona’s established profile by a critic agent for consistency. This is research with documented methodology, not improvisation dressed up as research.
Honest framing about what synthetic respondents are and aren’t. Synthetic personas are evidence-grounded constructs derived from published research about populations. They are not real patients or members. They cannot substitute for real-respondent data in regulated submissions, clinical claim validation, or anywhere the ground truth requires actual lived experience.
Synthetic research is the right tool for healthcare and regulated CX teams in these situations.
Early concept testing on described experiences. A new benefit framing, the positioning for a telehealth offering, the language of a claims-process change, a member-engagement program concept, a value proposition for medication adherence. Synthetic personas react to text descriptions of the concept (not to visual mockups or interactive flows) and surface directional signal in hours instead of months of panel recruitment. See concept testing. Candor doesn’t support multimodal interaction with mockups, wireframes, or prototype frames today. If the concept depends on the persona seeing a designed screen or clicking through a flow, real-user usability testing remains the right tool. Multimodal prototype walkthrough is a candidate future direction, not a shipping capability.
Journey-mapping hypotheses. Before committing to a multi-month member-journey research project, stress-test the hypothesized journey against an evidence-grounded synthetic population. Identify the segments where the hypothesis holds and the segments where it breaks. See problem discovery.
Member-experience exploration. Synthetic interviews about pain points, current workarounds, satisfaction drivers, and dissatisfaction triggers, across multiple member segments in parallel, in a fraction of the time real panels take.
Hypothesis sharpening for downstream research. When you have panel budget to spend on a real-member study, synthetic research sharpens the question set and the audience criteria first, so the panel round concentrates budget on the questions worth real-respondent investment. See assumption validation.
Message and value-prop testing for member-facing communications. Five message angles, eight personas, 40 reactions, in hours. Useful for member-acquisition campaigns, enrollment messaging, benefit education, claims-experience copy.
Honesty matters here because the wrong framing creates legal and compliance risk. Synthetic research doesn’t replace real-patient or real-member research for the following.
Clinical claim validation. Anything substantiating a clinical claim, going on a label, or supporting a regulatory submission requires real-respondent data with documented methodology. Synthetic research is not appropriate here.
Regulatory submissions and accreditation work. FDA submissions, HEDIS reporting, CAHPS-style measurement, NCQA accreditation evidence. All of these require real-respondent data with the methodology documentation those bodies expect.
Compliance-bound member research with regulatory exposure. Anything where the research itself is part of a regulatory program (HEDIS member-survey, CAHPS, MIPS) needs the real-respondent methodology those programs specify.
Prototype and design usability testing. Candor doesn’t support multimodal review of mockups, wireframes, or prototype frames. Synthetic personas react to described concepts in text, not to designed screens. If the research question is “does this member-app screen make sense” or “does this enrollment flow work as designed,” real-user usability testing is the right tool. Multimodal prototype walkthrough is a candidate future direction, not a shipping capability.
In-market member behavior. Real claims data, real app usage, real satisfaction tracking. The ground truth of what real members did. Synthetic research can hypothesize about these patterns. It can’t measure them.
Final validation for member-facing launches at scale. When you’re about to launch a member experience to 200,000 members, the final gate should include real-member testing alongside whatever synthetic work informed the design.
A useful test: if the research question is “what shape does this member experience take, for whom, and what reasoning do they apply to it,” synthetic research is in scope. If the question is “is this defensible to the regulator, the medical board, or the launch committee with real-respondent data behind it,” real-respondent research is required.
Synthetic respondents are not real patients or members, so the HIPAA Privacy Rule protections that apply to real PHI don’t attach to a synthetic respondent’s responses. The synthetic respondent is an evidence-grounded construct, not a person.
The more practical question is what happens to documents and data customers upload as input to Candor. Our recommendation is straightforward: anonymize before uploading. Strip patient and member identifiers, remove PII, and rely on de-identified research as input. Candor’s evidence-retrieval workflow doesn’t require identified data to produce useful personas. Published patient research, peer-reviewed studies, internal strategy documents, market research summaries, and de-identified journey maps all work well as input. Most healthcare and regulated CX teams using Candor are already operating this way without needing to upload identified data.
See /subprocessors and /privacy for current data-handling documentation.
The pattern for a healthcare or regulated CX team running Candor alongside existing panel methodology:
Total elapsed wall-clock for a single discovery study is roughly 1 to 2 hours of continuous work, though most CX teams let the background stages run while doing other work, so active attention is closer to 30 to 60 minutes. The bigger picture: a research question that previously sat in a 3-month recruitment queue can now produce respondent-grounded signal in an afternoon, with the panel work concentrated on the questions that genuinely require real members.
To see how Candor compares to other research approaches, read Candor vs traditional research panels, Candor vs UserTesting, or the full comparison hub. For the category overview, see what is synthetic user research. For the platform walkthrough, see how Candor works. For role-adjacent landers, see Candor for product discovery teams and Candor for consumer insights teams.
Be the first to know when it launches.
No spam. Just a note when Candor is ready. Powered by Highline Beta.